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Simplifying the Delivery of Melanocytes and
Keratinocytes for the Treatment of Vitiligo Using
a Chemically Defined Carrier Dressing
Paula C. Eves1, Nial A. Bullett2, David Haddow2, Alison J. Beck1, Christopher Layton3, Louise Way1,
Alex G. Shard1,4, David J. Gawkrodger5 and Sheila Mac Neil1
Obtaining pigmentary function in autologous skin grafts is a current challenge for burn surgeons as is
developing reliable robust grafting strategies for patients with vitiligo and piebaldism. In this paper, we present
the development of a simple methodology for delivering cultured keratinocytes and melanocytes to the patient
that is of low risk for the patient but also user friendly for the surgeon. In this study, we examined the ability of
keratinocytes and melanocytes to transfer from potential cell carriers under different media conditions to an
in vitro human wound bed model. The number of melanocytes transferred, their location within the
neoepidermis, and their ability to pigment were evaluated as preclinical end points. Two inert substrates
(polyvinyl chloride and silicone sheets) and three candidate plasma-polymerized coatings with controlled
surface chemistry deposited on these substrates were explored. Two media for expansion of cells, Greens,
currently used clinically (but which contains fetal calf serum), and a serum-free alternative, M2 (melanocyte
medium), were explored. Reproducible transfer of physiologically relevant numbers of melanocytes capable of
pigmentation from the coculture of melanocytes and keratinocytes was obtained using either Greens medium
or M2 medium, and a silicone carrier pretreated with 20% carboxylic acid deposited by plasma polymerization.
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INTRODUCTION
The pathophysiology of vitiligo is acknowledged to be
complex. Although there may be several different etiologies,
irrespective of the cause of the vitiligo, patients eventually
lose functional melanocytes from their skin, resulting in
depigmented areas that rarely repigment spontaneously.
Treatment modalities remain palliative; there is still no
‘‘foolproof’’ way of curing vitiligo.
The majority of repigmentation strategies are aimed at
mobilizing melanocytes from unaffected pigmented sites and
also from melanocyte reservoirs within hair follicles. Such
mobilization can be observed following UV phototherapies,
where repigmentation occurs via a perifollicular pattern or
from the periphery of the lesion (Kanwar and Parsad, 2006).
Over the last few decades, the phototherapy treatment most
widely used is UV therapy combined with oral or topical
psoralens (PUVA). Although a popular choice, PUVA
treatment does not consistently provide the desired results;
while some degree of repigmentation is achieved in 60–80%
of patients, a satisfactory response is obtained in only 20% of
cases (Mutalik and Ginzburg, 2000; Passeron and Ortonne,
2006). Furthermore, PUVA strategies can be tedious and are
continued over many months with the number of treatments
required ranging from 50 to 300, and the areas lacking
melanocyte reservoirs within the hair follicle are unlikely to
respond well. Other problems are the well-documented side
effects of drug intolerance, burns, and prolonged photo-
sensitivity, as well as the long-term risks of cancers and
melanomas in the skin (Mutalik and Ginzburg, 2000; Wang
et al., 2001).
Newer therapies with fewer side effects such as narrow-
band UVB phototherapy, targeted light/excimer laser therapy,
topical immunodulatory therapy, and calcipotriol in combi-
nation with UV light offer alternatives to standard PUVA
therapy (Grimes, 2004). Nonetheless, in spite of these
advancements, obtaining diffuse repigmentation remains a
problem.
The concept of treating vitiligo surgically was first
pioneered in the 1960s. Commonly, surgical procedures are
only offered to patients who prove refractory to medical
treatments and only for those patients who have had
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completely stable and non-progressive vitiligo for at least 1–2
years. The range of techniques for the surgical treatment of
vitiligo has been reviewed recently, and in brief (as it will be
summarized in the Discussion section) it can be divided into
those that do not involve expansion of cells in the laboratory
and those that do. Without cell expansion, it is possible to
treat small areas successfully, but cell culture is required to
expand melanocytes for more extensive areas of vitiligo. After
four decades of experience, it is possible to predict with
reasonable certainty which patients will do well (those with
segmental vitiligo), which areas to avoid (the hands), and
what the key issues are. With attention to the former,
repigmentation rates of 80–100% have been reported
(Falabella, 1983; Mutalik, 1993; Agrawal and Agrawal,
1995; Kahn and Cohen, 1995). However, despite this, the
majority of patients with vitiligo are not able to access this
approach to repigmentation, as most studies have not
progressed beyond clinical research studies to validate the
methodologies. Essentially, for a variety of reasons, they have
not made the transition to routine clinical use.
We previously attempted to treat vitiligo patients using
autologous cultured epithelial autografts (Phillips et al.,
2001), but effective repigmentation was achieved in only
one out of the five treated patients, although all healed well.
Further investigation showed that as the keratinocytes
achieved high density and differentiated to form confluent
sheets, any ‘‘passenger melanocytes’’ present in the cultures
were aggressively reduced in number and downregulated
with respect to their pigmentary capability (Phillips et al.,
2001; Mac Neil and Eves, 2006). Following on from this, we
decided to develop a carrier dressing that would be suitable
for the delivery of a subconfluent coculture of keratinocytes
and melanocytes. This follows on logically from chemically
defined carrier dressings that we have developed for the
delivery of autologous keratinocytes for the treatment of
patients with extensive burns and chronic wounds as detailed
by France et al., 1998a, b, Haddow et al., 1999, 2003,
Higham et al., 2003; Moustafa et al., 2004, 2007; Zhu et al.,
2005.
We have examined a range of chemically defined surfaces
and a range of media options (Beck et al., 2003; Eves et al.,
2005) and identified several combinations of surfaces in
media that would allow the successful expansion of
melanocytes and keratinocytes on these potential carrier
dressings.
However, to develop a robust technique of delivering
keratinocytes and melanocytes from the laboratory to the
patient, the next stage of the work was to assess to what
extent melanocytes and keratinocytes would transfer from the
dressing to make a new epithelium with appropriate numbers
of melanocytes capable of pigmentation. Additionally, we
were interested to see if this could be achieved using an
animal product-free culture methodology throughout.
Accordingly, in this study, we compared two potential
carriers (polyvinyl chloride (PVC) and silicone), three
candidate plasma-polymerized surfaces deposited on these,
and two media, Greens and M2 (a serum-free melanocyte
medium that has been used previously in the treatment of
vitiligo). We assessed the ability of keratinocytes and
melanocytes to transfer post-culture from carriers onto a
three-dimensional in vitro human wound bed model,
assessing the ability of keratinocytes to form a new
epithelium and of melanocytes to locate appropriately within
this new epithelium in physiologically relevant numbers. We
also investigated whether these melanocytes were still
capable of pigmentation.
RESULTS
Previously we have demonstrated that keratinocytes and
melanocytes will attach and proliferate on a range of
chemically defined surfaces and that surface preference can
be altered depending on the cell type and media used (Beck
et al., 2003; Eves et al., 2005; Mac Neil and Eves, 2006). In
this study, we show that various chemically defined carrier
dressings are capable of supporting the transfer (over a period
of 48 hours) of melanocytes and keratinocytes onto an in vitro
wound bed model.
Media choice
On the basis of previous work, two clinically relevant media
have been chosen for this study. The first is Greens medium,
which has been used clinically for over 30 years, but contains
10% bovine serum. Although this medium is specifically
designed for keratinocyte growth, it will support the
subconfluent coculture of melanocytes and keratinocytes
(Eves et al., 2005). The second is M2 medium, which
contains no xenobiotics or serum and has been developed for
melanocyte proliferation. Although this medium has not been
used clinically in the United Kingdom, it has been used
successfully to treat vitiligo patients in Europe (Olsson and
Juhlin, 1993, 1995, 1998; Olsson et al., 1994). We have
demonstrated that M2 medium will also support keratinocyte
growth and increases melanocyte numbers in coculture with
keratinocytes (Eves et al., 2005). Also, as the morphology of
melanocytes grown in M2 can appear to vary considerably
from donor to donor and with various passage numbers, the
medium MCDB153, optimized for melanocyte culture
in vitro, was also used for comparative surfaces. Although
MCDB153 was included for research purposes in this study, it
is not being considered for taking further into the clinic
because of the inclusion of bovine pituitary extract, tumor
promoters, and cholera toxin.
Carrier dressing choice
Two types of inert carrier dressings were compared: medical
grade PVC and an inert medical grade silicone polymeric
support. Initially work was carried out using PVC carriers.
However, very early in these studies it was found that
although melanocytes and keratinocytes attached to the PVC
surface (which was used with and without a plasma
polymerized functional surface), cell transfer onto human
de-epidermized acellular dermis (DED) was often poor (as
illustrated in Figures 1a, b and 2). While transfer in general
remained poor from the PVC carrier, plasma polymerization
of the PVC with 20% carboxylic acid did significantly
improve cell transfer onto human DED for both cocultures
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of melanocytes and keratinocytes using melanocytes estab-
lished in M2 (Figure 2a) and MCDB153 (Figure 2b).
However, as cell transfer was still poor from both the
untreated and treated PVC, this carrier was not taken further
in these studies. The observed poor transfer created a
technical problem, as the principle behind the use of a
plasma-polymerized carrier dressing was to create a surface
chemistry that would allow the attachment and proliferation
of cells on the carrier, but also enable the cells to be easily
transferred onto a patient wound bed. Other technical
problems with the PVC carriers were that they were difficult
to handle and had a high static charge. This sometimes made
it difficult to orientate the carrier so that the functionalized
surface was uppermost, and it also proved difficult to
maneuver the carriers onto the DED.
The second choice of carrier, medical grade silicone, was
thicker and more expensive than the PVC, but was much
easier to handle and did not have a high static charge. Initial
studies of the carrier alone with no plasma-polymerized
coating demonstrated that while cocultures of melanocytes
and keratinocytes attached well to the carrier, they also
almost always completely transferred to the in vitro wound
bed (DED) model (Figure 1c–e). This was observed with both
cocultures of keratinocytes and melanocytes (Figures 1d and
2) and also for freshly isolated keratinocyte cultures (in M2
and Greens media) containing passenger melanocytes (Figure
1e and Table 1). Different polymer coatings were then
deposited on the silicone carrier; these included 20%
carboxylic acid, 5% carboxylic acid, and 100% allylamine.
A comparison of cocultures using melanocytes established in
a
b
c
d
e
Figure 1. Transfer of keratinocyte/melanocyte cocultures from chemically
defined carrier dressings onto human DED. Cocultures or freshly isolated
cultures of keratinocytes and melanocytes (originally expanded in M2
medium) were placed on carrier dressings (a) PVC or (c) silicone for 24 hours
before transfer to DED for 48 hours. Cell transfer onto DED was assessed by
MTT staining. (a) PVC carriers coated with 20% carboxylic acid and post-
transfer MTT staining of cells showing that the majority of the cells have
remained on the carrier. (b) Transfer of the cells from the PVC carriers to the
DED with comparatively poor transfer. (c) Silicone carriers coated with 20%
carboxylic acid after transfer. All cells have left the carrier dressings. A dotted
line indicates the outline of one of the carrier dressings, which are hard to
visualize. (d) Transfer of cocultures of cells from the silicone carrier dressings
coated with 20% carboxylic acid to the DED showing that the majority of
cells have transferred from the dressing to the wound bed. (e) Successful
transfer of freshly isolated cells in M2 medium from the silicone carrier
dressings coated with 20% carboxylic acid to the DED.
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Figure 2. Assessment of the viability of cocultures of keratinocytes and
melanocytes (2:1 ratio) that have transferred onto a DED wound bed model.
All cells were cultured on the respective supports and engineered surfaces as
indicated in the figure for 24 hours before transfer to the DED for 48 hours.
Cells that were transferred to the DED were assessed for viability by MTT-
ESTA. (a) Melanocytes were initially established in M2 medium and then
combined in a 2:1 ratio with keratinocytes and transferred to Greens medium.
(b) Melanocytes were initially established in MCDB medium and then
combined in a 2:1 ratio with keratinocytes and cultured in Greens medium for
transfer onto the human DED. Results shown are means±SEM. Replicate
values are 6–15 throughout. PVC, polyvinyl chloride; CA, carboxylic acid;
AA, allylamine. Statistical analysis of cell transfer from the untreated PVC
versus plasma-polymerized PVC and between untreated silicone carriers and
the three different plasma-polymerized surfaces was determined by unpaired
Student’s t-test. **Po0.01, ***Po0.001.
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M2 medium (Figure 2a) and MCDB153 medium (Figure 2b)
showed very similar findings. Although cells transferred from
20% carboxylic acid-coated silicone were slightly more
viable than those from uncoated silicone, there was no
significant difference between the two carriers (Figure 2a
and b). However, cocultures transferred from both 5%
carboxylic acid- and 100% allylamine-coated silicone were
significantly less viable than the uncoated silicone surface
(Figure 2a and b).
Similar experiments were carried out for freshly isolated
cultures of keratinocytes (containing passenger melanocytes)
that had been cultured in either Greens or M2 medium. In
these experiments, the 20% carboxylic acid plasma polymer-
coated silicone carrier transferred cells that were significantly
more viable in both Greens and M2 media than the uncoated
silicone carrier (Table 1). In contrast, there were no
significant differences between the untreated silicone and
the 5% acid- or 100% amine plasma polymer-coated silicone
carriers (Table 1).
These findings indicate that cell attachment, transfer, and
viability can be altered according to the surface chemistry
employed. We have previously demonstrated that cell
preference for a chemically defined surface is also influenced
by the media or cell combination used. In fact, cocultures
were observed to be more viable than equivalent mono-
cultures (Eves et al., 2005). In an attempt to see if this was the
case with respect to cell transfer, comparison of transfer of
monocultures and cocultures from the untreated and 20%
carboxylic acid-treated silicone carriers was also made.
Transfer of monocultures versus cocultures
In this part of the study, keratinocytes and melanocytes alone
and in coculture were seeded at equivalent cell densities and
their viability post-transfer onto human DED was assessed. As
predicted from previous studies, coculture viability was
significantly higher than equivalent keratinocyte monoculture
viability (Figure 3). This was evident when both the uncoated
(Figure 3a) and 20% carboxylic acid-coated (Figure 3b)
silicone carriers were used. A similar significant increase in
viability was observed between melanocyte monocultures
and the cocultures for both the untreated (Figure 3a) and 20%
carboxylic acid-coated (Figure 3b) silicone carriers. Interest-
ingly, melanocytes in monoculture were also significantly
more viable than keratinocyte monocultures. As we have also
observed previously (Eves et al., 2005), the cocultures
containing melanocytes established in M2 medium were
more viable than those established in MCDB153 medium.
Although there were significant differences with regard to
mono- versus cocultures, no significant difference in viability
was observed between the untreated and 20% carboxylic
acid-treated silicone carriers. Although plasma polymeriza-
tion of the silicone did not affect cell attachment and transfer,
these data were reassuring, as the strategy of grafting
keratinocytes and melanocytes as a coculture remains an
attractive alternative to transplanting melanocytes alone,
especially as the keratinocytes ensure rapid healing with no
scarring, whereas the melanocytes pigment the transplanted
areas.
Ability of transferred cells to form a neoepithelium
In addition to looking at the viability of cells post-transfer
from the various chemically defined carriers, some samples
of DED plus cells were placed on stainless steel metal grids
and flooded with Greens medium to create an air–liquid
interface. This enabled the samples to develop into in vitro
models of human skin. After 10–14 days, the composites were
collected and underwent routine histological staining
with eosin and hematoxylin and immunostaining for the
S100 antibody, which identifies the presence of human
melanocytes. Both untreated and plasma-polymerized carrier
dressings transferred cocultures of melanocytes and kerati-
nocytes, which were able to form in vitro models of human
skin as illustrated in Figure 4i, ii, and iii. Hematoxylin and
eosin staining (Figure 4a and b) showed the presence of a
well-integrated and progressively differentiated epithelium,
whereas S100 staining showed the presence of melanocytes
located correctly among the basal keratinocytes (Figure 4c
and d). Semiquantitative analysis (melanocyte numbers were
counted across each section and then scaled up to establish
numbers per mm2) was carried out on 129 sections of the skin
composites to assess how melanocyte density affected the
overall number of cells and whether or not the different
Table 1. MTT data of freshly isolated keratinocytes (grown for 10 days in either M2 or Greens medium) transferred
from different chemically defined carriers onto human DED
Cell viability (MTT OD 540–630nm)
Silicone (mean±SEM) Silicone+20% CA (mean±SEM) Silicone+5% CA (mean±SEM) Silicone+100% AA (mean±SEM)
FK(Gns) FK(M2) FK(Gns) FK(M2) FK(Gns) FK(M2) FK(Gns) FK(M2)
0.055±0.004
(n=16)
0.049±0.002
(n=16)
0.079***±0.002
(n=10)
0.060**±0.002
(n=10)
0.046±0.002
(n=7)
0.047±0.003
(n=7)
0.045±0.003
(n=5)
0.041±0.003
(n=7)
AA, allylamine; CA, carboxylic acid; DED, de-epidermized acellular dermis; FK, freshly isolated keratinocytes; Gns, Greens medium; M2, melanocyte
medium; MTT, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide.
Statistical analysis (unpaired t-test) of cell transfer on the different plasma-polymerized silicone carriers was in all cases compared to cell transfer on
untreated silicone carriers for freshly isolated cells in Greens or M2 medium. Statistical significance was achieved between untreated and 20% CA-treated
silicone carriers for cells cultured in Greens and M2 media.
**Po0.01 and ***Po0.001.
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surface chemistries affected the number of melanocytes
transferred onto the human DED. Table 2 illustrates the
results of this analysis.
The melanocyte/keratinocyte cocultures (with melano-
cytes grown in M2 medium) were seeded at a 1:2 ratio, which
is artificially high; however, we wanted to ensure that enough
melanocytes were transferred over to the in vitro skin model.
In contrast to the viability data, melanocyte counts transferred
from the 20% carboxylic acid-coated carriers were highest,
followed by the 5% acid- and 100% amine-coated carriers,
whereas melanocyte counts were lowest on the untreated
silicone carriers. A significant increase in melanocyte
numbers transferred from the 20% carboxylic acid silicone
carrier was observed when compared to the untreated
silicone (Table 2). Melanocyte numbers ranged from 1,358
to 2,705 melanocytes per mm2. As the normal melanocyte
numbers in human skin range from 1 to 2,000 melanocytes
mm2, our data imply that the keratinocytes transferred with
the melanocytes are very good at regulating melanocyte
number, even in an in vitro model of human skin.
We also looked at melanocyte numbers in freshly isolated
keratinocyte populations (which normally have 2–3% pas-
senger melanocytes present), after they had been cultured in
either Greens or M2 medium for 7–10 days. Although there
was a lot of variation between different skin donors, no
significance was achieved and the melanocyte numbers
transferred from all the different carriers were higher in M2
medium than that in Greens medium. Although not
significant, these data support previous findings demonstrat-
ing that melanocyte numbers in M2 medium are boosted
compared to similar cultures in Greens medium. The
melanocyte numbers present in the freshly isolated keratino-
cyte populations varied from 691 to 1,567 melanocytes per
mm2. This number of melanocytes is still within the range of
what you would expect to see normally and suggests that this
methodology may also be a viable option for treating vitiligo
patients in the future.
The fact that melanocyte numbers were greatest when
they had been cultured in the M2 medium and following
transfer from the 20% carboxylic acid-coated silicone may
indicate that the most effective way of delivering melanocytes
to patients will be via a 20% carboxylic acid carrier in
combination with melanocytes cultured in M2.
Assessment of melanocyte pigmentation pre- and post-transfer
The final stage of the work was to confirm that melanocytes
retained their pigmentary ability when cultured on the carrier
dressings and post-transfer to the reconstructed skin. This is
particularly important as the skin used in our experiments
and donated to our laboratory is rarely spontaneously
pigmented, as it comes from skin types I and II. So far, we
have demonstrated that cocultures of melanocytes can be
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Figure 3. Keratinocyte and melanocyte transfer onto human DED from
untreated silicone and silicone treated with 20% carboxylic acid.
Keratinocytes and melanocytes were cultured alone and in coculture
(at equivalent cell densities) as indicated and their transfer from (a) untreated
silicone and (b) 20% carboxylic acid-coated silicone compared. Results
shown are means±SEM (N¼ 6). K, keratinocytes; M, melanocytes; MCDB,
MCDB153 medium; M2, M2 melanocyte medium. Statistical analysis of
keratinocyte monoculture was compared to that of melanocyte monoculture
and all cocultures using a Student’s unpaired t-test. Statistical significance
between melanocyte monocultures and respective cocultures was also
determined for melanocytes established in both MCDB and M2. *Po0.05,
**Po0.01, ***Po0.001.
a b
c d
e f
Figure 4. Production of neodermis containing melanocytes after transfer of
cultured keratinocytes and melanocytes from carrier onto human dermis.
Photomicrographs (i–iii) and histology (a–f) of skin composites after
keratinocyte/melanocyte cocultures have been transferred onto human DED
from 20% CA plasma-polymerized silicone carriers and cultured for 2 weeks
at an air–liquid interface. (a, b) Histological sections have been stained with
hematoxylin and eosin (H and E) to illustrate skin cell morphology; (c, d) S100
to illustrate the presence of melanocytes; (e, f) Mel-5 to illustrate melanocytes
with melanogenic activity. Bar¼ (a, c, e) 40 mm and (b, d, f) 20 mm.
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successfully cultured and transferred from various chemically
defined carrier dressings onto an in vitro model of human
skin. Furthermore, these transferred cells can be left to
establish a very realistic model of human skin. Although
melanocyte numbers in the in vitro skin composites have
been shown to be within the range of what would be
expected in vivo, there is no point in translating the work into
the clinic if the melanocytes have no pigmentary capability.
As illustrated in Figure 4i, ii, and iii, there was no visual
increase in pigmentation in the skin composites while they
were being cultured at an air–liquid interface. However, this
was to be expected as the skin cells isolated and used in the
experiments were donated from skin types I and II. Accord-
ingly, we used dopa oxidase staining and immunohistochem-
ical techniques to assess the pigmentary ability of the
melanocytes both pre- and post-transfer.
For the pre-transfer studies, mono- and cocultures of
melanocytes and keratinocytes were established on untreated
and 20% carboxylic acid-treated carriers, incubated for
24 hours, and then subjected to dopa oxidase staining.
Dopa-positive melanocytes were present on the carriers in
both the monocultures (Figure 5a and b) and the cocultures
(Figure 5c and d). For the post-transfer studies, cocultures of
melanocytes and keratinocytes that had been transferred from
untreated and 20% carboxylic acid-treated silicone carriers
onto human DED and cultured for further 10 days at an
air–liquid interface were collected and immunostained for the
presence of tyrosinase protein-1 using the Mel-5 antibody.
Tyrosinase protein-1 (Mel-5 antibody) detects a 75 kDa
glycoprotein expressed by normal melanocytes, nevi, and
melanoma cells (Bhawan, 1997) and should indicate
melanocytes that are capable of producing a pigment. As
illustrated in Figure 4e and f, all the melanocytes present in
the skin composites were strongly positive for the Mel-5
antibody, thus indicating that the melanocytes had retained
their pigmentary ability in vitro.
DISCUSSION
The overall aim of this research is to develop a cell carrier
and culture system that will help translate the use of a
cultured cell therapy for vitiligo patients toward a routine
clinical service. In this study, we assessed the performance of
melanocyte and keratinocyte coculture on potential cell
carriers in various media and followed their transfer to an
in vitro wound model.
In brief, the study allowed us to determine a combination
of an inert substrate (medical grade silicone), an engineered
surface (20% carboxylic acid deposited by plasma polymer-
ization), a cell seeding ratio (keratinocytes to melanocytes,
2:1), and a medium (best results were obtained by expanding
melanocytes in M2 and keratinocytes in Greens, and then
doing the coculture and transfer under Greens medium
conditions), which gave good transfer of both keratinocytes
and melanocytes for future clinical use.
Table 2. Melanocyte numbers from sections of skin
composites (stained with S100) after transfer of cells
from untreated and plasma-polymerized carriers and
further culture at an air–liquid interface for 10 days
Silicone
K+M(M2) 1,478±375 (n=8)
FK(Gns) 1,156±123 (n=12)
FK(M2) 1,240±165 (n=12)
Silicone+20% CA
K+M(M2) 2,745*±240 (n=10)
FK(Gns) 958±119 (n=9)
FK(M2) 1,511±285 (n=10)
Silicone+5% CA
K+M(M2) 2,261±237 (n=9)
FK(Gns) 765±82 (n=11)
FK(M2) 1,131±236 (n=12)
Silicone+100% AA
K+M(M2) 1,553±211 (n=8)
FK(Gns) 675±73 (n=12)
FK(M2) 1,423±223 (n=12)
AA, allylamine; CA, carboxylic acid; FK, freshly isolated keratinocytes;
Gns, Greens medium; K, cultured keratinocytes; M, cultured melanocytes;
M2, melanocyte medium.
Statistical analysis (Mann–Whitney) of melanocyte numbers present in
sections of skin composites following transfer from the different plasma-
polymerized silicone carriers was in all cases compared to melanocyte
numbers transferred from untreated silicone carriers. For the freshly
isolated cultures, statistical comparisons were also made between the
Greens and M2 media for all the different carrier dressings used. Statistical
significance was achieved between untreated and 20% CA-treated
silicone carriers for melanocyte numbers present as part of a 2:1 coculture
of keratinocytes/melanocytes (K+M(M2)).
Values represent melanocyte numbers per mm2 (mean±SEM).
*Po0.05.
a b
c d
Figure 5. Dopa oxidase staining of melanocytes alone and in coculture with
keratinocytes on uncoated silicone carriers pretransfer onto human DED.
Melanocytes were cultured alone in (a) MCDB and (b) M2. Cocultures of
melanocytes and keratinocytes in (c) MCDB and (d) M2. Bar¼ 100mm.
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As will be appreciated from the above, there are many
variables in optimizing such a system, and it is essential that
before going to the clinic one can demonstrate the robustness
and reliability of the culture system and performance of the
cells after transfer from the carrier. Additionally, this study
yielded further valuable information on the extent to which
cocultures of cells can outperform monocultures.
Repigmentation of depigmented areas for vitiligo patients
remains a challenge as discussed in the introduction.
Repigmentation tends to be very slow with conventional
medical therapies and does not work for all patients.
Repigmentation can be achieved for a considerable percen-
tage of vitiligo patients, however, following a surgical
approach of transplanting autologous melanocytes. Surgical
treatment of vitiligo has been reviewed in depth recently
(Gupta et al., 2006). In brief, the first surgical technique used
in the 1960s was thin dermo-epidermal grafting (Behl, 1964).
This was followed in the late 1980s and early 1990s by split-
thickness skin grafts, suction epidermal grafting, punch
minigrafting, non-cultured epidermal suspensions, and
epithelial autografts (Falabella, 1971, 1983, Gauthier and
Surleve-Bazeille, 1992; Mutalik, 1993; Agrawal and Agrawal,
1995; Kahn and Cohen, 1995; Olsson and Juhlin, 1997,
1998; Van Geel et al., 2001; Mulekar, 2003). Provided
vitiligo patients had stable forms of vitiligo and good
dermabrasion techniques were used, good success rates were
achieved using all of the above techniques. Although these
grafting techniques have resulted in success rates ranging
from 68 to 88%, their main drawback is that they are only
useful for the treatment of small localized lesions.
In an attempt to treat larger areas of vitiligo, autologous
melanocytes and keratinocytes from pigmented areas on the
patient have been expanded in vitro before being trans-
planted back onto the vitiligo site. Treatments have included
the use of cultured epidermal autografts (Falabella et al.,
1992a, b; Lontz et al., 1994; Guerra et al., 2000; Phillips et al,
2001) and cultured pure melanocyte suspensions (Olsson and
Juhlin, 1993, 1995, 2002; Lontz et al., 1994; Olsson et al.,
1994; Kaufmann et al., 1998; Chen et al., 2004). These
studies resulted in 70–90% homogeneous repigmentation in
patients with stable forms of vitiligo. However, a major
drawback with using cultured cells on large areas of vitiligo is
keeping the cell suspensions in place on curved and difficult-
to-treat areas. Van Geel et al. (2001, 2004) have tried to
improve cell adherence to the recipient site by introducing
hyaluronic acid to these epidermal suspensions.
The methodology developed in this study is based on a
technology that is currently being used to deliver large
numbers of keratinocytes to patients with extensive burn
injuries (Zhu et al., 2005) and chronic wounds (Moustafa
et al., 2004, 2007). It consists of a chemically defined carrier
dressing (which is itself free of all animal products) onto
which the cells are placed. Cells are delivered to the patient’s
wound on the carrier dressing and are placed with the cells
facing down into the wound bed, thus allowing cells to
transfer from the dressing to the wound. Our prior experience
in delivering keratinocytes in this way has shown that these
flexible carriers can be easily placed onto difficult and curved
regions of the body and then gently held in place with
conventional dressings, and they prove easy to use. A single
blind study using this methodology for the treatment of
diabetic ulcers has recently been completed (Moustafa et al.,
2007).
Previously we have demonstrated that melanocytes and
keratinocytes alone and in coculture will attach and grow on
a range of chemically defined surfaces (Beck et al., 2003;
Eves et al., 2005). The logical step from this work was to then
assess how well cells will transfer from these surfaces onto an
in vitro wound bed. Initially the work involved looking at
two carrier dressings, medical grade silicone and PVC.
From early on, it was evident that although cells would
attach to the PVC carriers, they would not then transfer
across to the human dermis. In contrast, cells transferred
with almost 100% efficiency from the silicone carrier
dressings. This may be explained by the fact that the PVC is
an organic polymer that enables better adhesion of the
plasma polymer coating, whereas silicone is an inorganic
substrate that results in poorer adhesion of the plasma
polymer to its surface.
The most efficient carrier dressings with respect to cell
transfer were the untreated silicone and the silicone treated
with 20% carboxylic acid. The fact that 100% cell transfer
from these surfaces after 48 hours onto an in vitro wound bed
model was achieved is reassuring, as in the clinic, dressings
would normally be left in place for at least 7 days (thus
allowing plenty of time for cell transfer to take place).
Although there were no significant differences with these two
carriers following transfer over 48 hours, the 20% plasma-
polymerized silicone carrier outperformed the untreated
carrier when melanocyte numbers present in the resulting
skin composites were counted. This may be explained by the
fact that we have previously demonstrated human keratino-
cytes to perform well on a 20% carboxylic acid plasma-
polymerized surface (France et al., 1998a; Haddow et al.,
1999, 2003). Thus, we speculate that keratinocytes on this
20% carboxylic acid surface provide a more physiologically
relevant environment for the melanocytes in the cocultures.
(We also have some preliminary data to show that if the
carriers plus cells are transported for 48 hours before being
transferred to the human dermis, cell viability is better when
cells are transported on the 20% carboxylic acid plasma-
polymerized silicone carrier than on the untreated carrier
(unpublished data).)
There are many reports in the literature demonstrating that
cells in coculture are more robust than monocultures. We
have confirmed these findings by demonstrating that cell
viability is significantly improved when keratinocytes are
combined with melanocytes. This was particularly evident
with cocultures using melanocytes established in M2
medium. These data also support previous findings compar-
ing mono- and cocultures in the M2 medium (Eves et al.,
2005) and further demonstrate the important synergistic effect
that melanocytes and keratinocytes have on each other when
they are in direct contact. The fact that cocultures using
melanocytes established in M2 did better than those in
MCDB153 was also reassuring, as this medium is serum free
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and contains no toxins or tumor promoters unlike the latter
medium.
Rather than expanding keratinocytes and melanocytes
individually for 2–3 weeks and then combining them as a
coculture for the treatment of vitiligo patients, another viable
treatment option would be to isolate and culture (for 10 days)
autologous populations of freshly isolated keratinocytes that
have a passenger population of 1–3% melanocytes. We have
previously demonstrated that passenger melanocyte numbers
in these cultures can be increased if M2 medium is used (Eves
et al., 2005). Although not significant, the data from this study
support previous findings by demonstrating that greater
numbers of melanocytes can be transferred onto the in vitro
wound bed model following isolation and culture in M2
medium than that in Greens. This was especially evident with
the 20% carboxylic acid-coated carriers. We have also
demonstrated that cell transfer was significantly better from
the 20% carboxylic acid carriers (as detailed in Table 1). A
simple explanation for this is that the freshly isolated cultures
are used after only 10 days in culture and are therefore more
reliant on the 20% carboxylic acid coating than on the
untreated silicone. In comparison, keratinocytes and mela-
nocytes used for the cocultures have been expanded in
culture in a mitogen-rich medium for several weeks and
hence attach well to both untreated and plasma-polymerized
surfaces.
In summary, this extensive study has looked at a number
of variables for optimizing a carrier dressing system for the
delivery of cocultures of autologous melanocytes and
keratinocytes for repigmentation of patients with vitiligo.
Several key interactions between keratinocytes and melano-
cytes have been identified, and the interaction of each cell
type with the surface carrier is different. However, with
respect to melanocyte numbers at the end of the transfer
process, the most favorable dressing to take forward
clinically is the 20% carboxylic acid-coated silicone carrier.
The study also leaves us with two possible routes for
melanocyte/keratinocyte culture. In the first, it is possible to
expand melanocytes in M2 medium (which has already been
used in the treatment of patients with vitiligo; Olsson and
Juhlin, 1993, 1995, 1998; Olsson et al., 1994) and
keratinocytes in Greens medium, and then combine both
cells and transfer the cocultures in Greens medium. Alter-
natively, freshly isolated autologous keratinocytes could be
cultured in M2 medium for 10–14 days to increase
melanocyte numbers before transfer to the patient. But again,
the most reliable transfer occurred in Greens medium
containing fetal calf serum (FCS). FCS sourced from Australia
and New Zealand has been used clinically for more than 10
years with no adverse side effects. However, in an attempt to
move away from animal-derived products, it may prove
possible to use a patient’s own serum instead of FCS
for the transfer procedure. Indeed, in vivo, carriers containing
keratinocytes and melanocytes in M2 medium when
placed on the patient’s wound bed will be immediately
exposed to the patient’s sera, which from our experience
in this study will help in the transfer of the cells to the
wound bed.
Regardless of the method used, this study has demon-
strated that the keratinocyte/melanocyte coculture transferred
from the various carriers onto a three-dimensional in vitro
wound bed will form a fully stratified neoepithelium contain-
ing physiologically relevant numbers of melanocytes that are
capable of pigmenting.
MATERIALS AND METHODS
Cell culture: human keratinocytes
Split-thickness skin grafts were obtained during routine plastic
surgery breast reductions and abdominoplasties (all patients had
signed a consent form allowing the use of tissues for research that
were not needed for clinical diagnosis). A modified Watson knife
was used to harvest the split-thickness skin grafts, which were placed
in sterile saline and stored at 4 1C until processing (within 72 hours).
Samples of this skin were cut into 0.5 2 cm2 pieces using a scalpel
blade and were incubated overnight (18 hours) at 4 1C in 10ml 0.1%
w/v trypsin (BD Biosciences, Oxford, UK). FCS (GlobePharm Ltd,
Cork, UK) was added to neutralize the trypsin, and the epidermal
and dermal layers were carefully separated using a pair of forceps
with fine points. A scalpel blade was used to gently scrape basal
keratinocytes from the undersurface of the epidermis and the
papillary surface of the dermis. The cells were collected into two
separate 25ml containers in a 1:1 mixture of FCS and phosphate-
buffered saline (Oxoid Ltd, Cambridge, UK). The cell suspension was
then centrifuged at 200 g for 5minutes, and cells were resuspended
in either a known volume of Greens medium or melanocyte culture
medium (M2). Greens medium consists of DMEM and Ham’s F12
medium (both from Gibco BRL, UK) in a 3:1 ratio supplemented with
10 ngml1 epidermal growth factor, 0.4mgml1 hydrocortisone,
1.8 104mol ll adenine, 5mgml1 insulin, 5mgml1 transferrin,
2 107mol l1 tri-iodothyronine (all from Sigma-Aldrich, Gillingham,
UK), 8.5 ngml1 cholera toxin, 0.625mgml1 amphotericin B,
100 IUml1 penicillin, 100mgml1 streptomycin (from Gibco BRL),
and 10% FCS. M2 is a highly balanced serum-free medium, based on
DMEM/Ham’s F12 (1:1, v/v) and a 15mmol l1 HEPES buffer system,
supplemented with 50 IUml1 penicillin, 50mgml1 streptomycin,
and 5ngml1 basic fibroblast growth factor (Promocell GmbH,
Heidelberg, Germany). A cell count was carried out using a
hemocytometer, and trypan blue (Sigma-Aldrich) exclusion was used
to assess cell viability. Freshly isolated cells at a cell density of
1–2 106 were seeded along with irradiated mouse 3T3 cells
(1 106) into T75 tissue culture flasks in Greens medium or at a
cell density of 2–4 106 cells in M2 medium (irradiated 3T3 cells
were not required when keratinocytes were cultured in M2 medium).
Cell culture: human melanocytes
Melanocytes were isolated in exactly the same manner as human
keratinocytes (described previously) using 0.1% w/v trypsin. As with
the keratinocytes, cell suspensions for melanocyte isolation were
collected into two 25ml containers. Once centrifuged, the cells
were resuspended and seeded at 1 105 cells per flask in either M2
medium or in a low-calcium MCDB153 basal medium (Sigma-
Aldrich) supplemented with 2% chelated FCS, 25 mgml1 bovine
pituitary extract (Gibco BRL), 10 mgml1 insulin, 10 mgml1
transferrin, 2.8 mgml1 hydrocortisone, 100 IUml1 penicillin,
100mgml1 streptomycin, 10Uml1 nystatin (Sigma-Aldrich),
100 ngml1 cholera toxin, and 10 nMl1 phorbol 12-myristate
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13-acetate (Sigma-Aldrich). Keratinocyte and fibroblast contamina-
tion was rarely seen in cultures of melanocytes grown in MCDB
medium. However, when cells were seeded in M2 medium, the
resultant culture consisted of mainly keratinocytes with a small
percentage of melanocytes and fibroblasts. After 7–14 days in
culture, with M2 re-feeds every 3–4 days, a large number of
melanocytes were evident among the keratinocyte colonies. These
melanocytes were harvested using a 30 seconds to 1minute
exposure to 0.1% w/v trypsin and 0.02% w/v EDTA (Sigma-Aldrich),
followed by a serum-free trypsin inhibitor (Cascade Biologics,
Mansfield, UK). Although no keratinocytes were evident in the
melanocyte cultures after 1–2 trypsin splits, fibroblasts were often
present. The majority of these could be removed with 100 mgml1
geneticin (Sigma-Aldrich), which was added to the medium for a
period of 3 days. Melanocyte cultures were fed twice weekly.
Melanocytes in both media were used between passages 2 and 6.
Preparation of DED
Split-thickness skin grafts suitable for use as dermal substrates were
stored at 4 1C in phosphate-buffered saline containing 100 IUml1
penicillin, 100mgml1 streptomycin, and 0.625 mgml1 amphoter-
icin B for a minimum of 7 days. The split-thickness skin grafts were
incubated in sterile 1M sodium chloride for 18 hours at 37 1C. After
18 hours, the epidermis was peeled away from the dermis and the
dermis was washed repeatedly with phosphate-buffered saline. The
dermal substrates (DED) were then stored at 4 1C in Greens medium.
Production of plasma-polymerized surfaces
Previously we have demonstrated that keratinocytes and melano-
cytes will attach and proliferate on a range of chemically defined
surfaces (Eves et al., 2005). Although cells attached to amine, acid,
and co-polymerized surfaces in this study, the biggest differences in
cell preference were observed between 100% acrylic acid (5%
carboxylic acid) and 100% allylamine. For this reason, these two
polymers (Aldrich Chemical Company, Gillingham, UK) were used
in this study. Two types of carrier dressing were also investigated: (1)
medical grade PVC and (2) medical grade silicone (Polymer Systems
Technology Ltd, High Wycombe, UK). For a number of years, PVC
carriers coated with a plasma-polymerized functional surface
containing 20% carboxylic acid have been used clinically for the
treatment of burns and chronic wounds (Moustafa et al., 2004; Zhu
et al., 2005). However, this carrier dressing has proved difficult to
handle and has been replaced with a medical grade silicone carrier.
In this study, PVC either alone or coated with 20% carboxylic acid
was compared to silicone both alone and with various plasma-
polymerized surfaces—20% carboxylic acid, 5% carboxylic acid,
and 100% allylamine. Plasma-polymerized surfaces were prepared
from vapors of either acrylic acid or allylamine, which were
deposited onto the carriers. The apparatus for plasma polymerization
comprised a 50 cm length glass reactor with stainless steel flanges
and an external copper coil electrode (Bullet et al., 2003). The
reactor was evacuated with a rotary pump with liquid nitrogen cold
trap, and the base pressure was approximately 103mbar. A flow
rate of 4 cm3STPmin
1 and plasma power of 5W were used for
preparation of the allylamine and 5% carboxylic acid surfaces, and a
flow of 10 cm3STPmin
1 and 1W of plasma power were used for the
20% carboxylic acid surfaces. Depositions were carried out over
10minutes.
Transfer experiments
In this study, two methods of applying cells to the carrier dressings
were investigated. The first involved isolating and expanding up
individual cultures of human keratinocytes in a keratinocyte-specific
medium (Greens), and human melanocytes in melanocyte-specific
media (MCDB153 and M2). After 2–3 weeks in culture, these
individual cultures were then used as a 2:1 coculture of keratino-
cytes/melanocytes in experimental studies. The second method
involved culturing freshly isolated keratinocytes (containing a
passenger population of melanocytes) in either Greens or M2 medium
for 7–10 days before being used on the various carrier dressings.
Whereas Greens medium promotes keratinocyte growth, we have
previously demonstrated that M2 medium allows expansion of
melanocyte numbers as well as keratinocytes (Eves et al., 2005).
Hence, we wanted to see if melanocyte numbers could be increased
in vitro over 7–10 days in the M2 medium compared to Greens
medium. For the coculture work, keratinocytes were used at 6 104
cells per carrier and melanocytes were seeded at 3 104 cells per
carrier. For the freshly isolated keratinocytes (containing passenger
melanocytes), cells were seeded at 9 104 cells per carrier. The three
media chosen for study included Green’s medium (developed for
keratinocyte culture), which has been used clinically for more than 20
years but contains FCS (which in our laboratory is sourced from New
Zealand for clinical work); MCDB153 medium, which was developed
for in vitro melanocyte culture but would not be appropriate for
clinical use, as it contains bovine pituitary extract, phorbol
12-myristate 13-acetate, and cholera toxin; and finally M2 melanocyte
medium, which is free from serum, pituitary extracts, and phorbol
esters and has been used clinically for the treatment of patients with
vitiligo (Olsson and Juhlin, 1993, 1995, 1998; Olsson et al., 1994).
Cells were seeded onto the plasma-polymerized carriers inside
0.8 cm diameter stainless steel rings and incubated for 24 hours at
37 1C. After this incubation time, the stainless steel rings were
removed and the carriers were placed cell side down on human
DED. Small stainless steel grids were placed on top of the carriers to
hold them in place, and the DED plus carrier were flooded with
media. After 24 hours at 37 1C, the grids were removed and the
dermis plus carriers were incubated for a further 24 hours. (In the
clinic, dressings would normally be left in place for at least 7 days.)
At this point, some of the carriers and dermis were separated and the
number of viable cells transferred from the carriers to the DED was
assessed using 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium
bromide-eluted stain assay (MTT-ESTA) (Sigma-Aldrich) analysis. For
the remaining samples, the carriers were removed and the DED plus
transferred cells were placed on stainless steel grids in new six-well
plates. Medium was added to each well, so that it lapped over the
edges of the grid and dermis but left the transferred cells exposed to
air. These skin composites were then cultured for further 10 days
with medium changes every 3–4 days. At the end of this culture
period, all samples were fixed with 10% buffered formalin and sent
for routine histology and immunohistochemical staining for S100
(Dako Corporation, Carpinteria, CA) and Mel-5 (Signet Laboratories,
Dedham, MA; Bioquote Limited, York, UK) antibodies. All transfer
experiments were carried out in Greens medium.
Histological and immunohistochemical analysis
Preparation of frozen and paraffin wax sections. Frozen
sections were cut on a Brights cryostat and transferred to
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poly-L-lysine-coated glass slides (BDH, Merck Ltd, Lutterworth, UK),
air-dried for 30minutes at room temperature, and fixed in glacial
acetone (Hillcross Pharmaceuticals, Burnley, UK) for 15minutes.
Sections were then air-dried and stored in slide trays, wrapped in
cling film to prevent desiccation during storage, and stored at 80 1C
for a maximum of several months. For paraffin wax sections, full
details are as described by Eves et al. (2005). Briefly, formaldehyde
(Genta Medical, York, UK)-fixed specimens were processed and
embedded in paraffin wax (Paraplast, Sherwood Medical, Deland,
FL), 4mm sections were cut from each tissue block, and whereas
some underwent routine histology (were stained with Carazzi’s
hematoxylin (Surgipath Medical Industries, Peterborough, UK)
and eosin (BDH Merck Ltd)), others were stored for immunohisto-
chemical analysis.
Immunohistochemistry. Whereas frozen sections were removed
from the 80 1C freezer and thawed, paraffin wax sections were
dewaxed, rehydrated, and washed as detailed by Eves et al. (2005).
Any masking of antigenic sites by the processing procedure was
reversed by the use of an antigen retrieval method—either enzyme
digestion or ultra-heat treatment (described by Eves et al., 2005).
Sections were blocked (using 1:25 horse serum for mAbs and 1:25
swine serum for polyclonal antibodies; both from Harlan Sera-Lab
Ltd, Loughborough, UK) for 10minutes to decrease background
staining, incubated with primary antibody (rabbit-derived S100
antibody, 1:2,500; mouse-derived Mel-5 antibody, 1:10) for
60minutes, washed with Tris-buffered saline/Tween (BDH, Merck
Ltd), and incubated with secondary antibody (biotinylated anti-
mouse secondary antibodies for monoclonals and biotinylated
anti-rabbit secondary antibodies for polyclonals; both from Vector
Laboratories, Peterborough, UK) for 30minutes. Antibodies were
visualized with an alkaline phosphatase Avidin Biotin Complex kit
and alkaline phosphatase substrate kit (Vector Laboratories) as
detailed by Eves et al. (2005).
Assessment of cell attachment/viability. Viability of transferred
cells was assessed using MTT-ESTA. Each carrier was separated from
the DED, and both the carrier and DED (cell side uppermost) were
placed in 12-well plates. A 1ml portion of MTT per carrier and 1.5ml
of MTT per DED (0.5mgml1 in phosphate-buffered saline) were
added to each well and the samples were incubated for 40minutes at
37 1C. During this incubation time, dehydrogenase activity in the cells
converts MTT to a colored formazan product, which can then be
eluted. After 40minutes, the MTT was removed and 500ml Cellusolve
(ethylene glycol monoethyl ether; Sigma-Aldrich) was added to elute
any colored formazan product formed within the cells on either the
carriers or the DED. Once eluted, 100ml of the formazan product
(triplicate samples) from each well was added to a 96-well plate and
the plate was read at 540nm with a reference filter of 630nm. Control
values for Cellusolve alone were subtracted from all readings, and the
mean optical densities were calculated.
Assessment of melanocyte numbers. In an attempt to assess the
number of melanocytes present in the skin composites following the
transfer of keratinocytes and melanocytes from various carrier
dressings onto human DED, S100 immunostaining was carried out
to identify the total number of melanocytes present. Semiquantitative
analysis was then carried out by counting the melanocytes present
per section of skin and calculating from the surface area of the
section how many melanocytes would be present per 1mm2.
Statistical analysis
Statistical significance was determined for the transfer data on the
different carrier dressings using a two-tailed, unpaired Student’s
t-test. Statistical analysis was also undertaken for the resulting
melanocyte numbers in sections of skin composites following
transfer from the various carriers, using the non-parametric
Mann–Whitney test.
Informed written consent was obtained from all patients enabling
the use of tissue that was ‘‘surplus to requirement’’ to be used for
research. The study was approved by the Regional Committee for
Research Ethics and by the University of Sheffield Research Office.
All experiments were conducted according to the Declaration of
Helsinki Principles.
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